Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

SAGE

SAGE News

Newswire

14:37

SAGE Therapeutics Announces Nasdaq Delisting Following Merger and Board Changes

14:37

Supernus Completes Acquisition of Sage Therapeutics, Aiming for Growth and Diversification in Brain Health Medicines

08:48

Supernus completes acquisition of Sage Therapeutics, adds ZURZUVAE revenue.

08:46

Supernus Pharmaceuticals Acquires Sage Therapeutics to Strengthen Presence in Neuropsychiatric Conditions

16:12

Sage Therapeutics Q2 revenue at $23.2mln, up 68% YoY.

View More

About SAGE

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More